Pilosed

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pilosed

Property Description
Active ingredient Pilocarpine Hydrochloride
Form Ophthalmic Solution, Oral Tablet
Pharmacological class Cholinergic Agonist (Muscarinic)
General Utility Management of elevated eye pressure; Stimulation of secretions (sialagogue)
Origin Synthetic Alkaloid Derivative

Pilosed is a prescription-only medicine defined by its single-ingredient active compound, Pilocarpine Hydrochloride, and is classified as a specialized agent that affects the body's involuntary nervous system. Its identity is dual, functioning as both an agent to manage elevated eye pressure and a substance that stimulates fluid production in the mouth and eyes, which dictates its two main forms. The utility of Pilocarpine Hydrochloride is based on its ability to target specific cholinergic pathways.


What is Pilosed and Its Composition?

The active compound in Pilosed is Pilocarpine Hydrochloride (INN), which is chemically defined as a Synthetic Alkaloid Derivative belonging to the imidazole alkaloid family. The medication is prepared primarily as an Ophthalmic Solution for topical administration to the eye, but it is also manufactured as an Oral Tablet for systemic administration. This dual availability is a differentiating factor, offering flexibility in therapeutic approach. The choice of form relates directly to its general benefit, utilizing a simple aqueous solution base for the eye drops or a standard excipient matrix for the tablet form.


What Type of Medicine is Pilosed? (Pharmacological Class)

Pilosed is fundamentally a Cholinergic Agonist, meaning it directly activates specific receptors within the nervous system, earning it the scientific classification of a Parasympathomimetic Agent. Specifically, it is a Muscarinic Agonist, mimicking the effects of the natural chemical acetylcholine to produce a therapeutic response. Pilocarpine Hydrochloride acts by directly stimulating muscarinic receptors. This action is central to its utility, defining why the drug causes specific muscles to contract and certain glands to secrete fluids.


What is the General Purpose of Pilosed? (High-Level Utility)

The general utility of Pilosed is to relieve conditions associated with a lack of bodily fluids and to assist with fluid dynamics within the eye. In its systemic oral form, its primary function is as a sialagogue, intended to cause the Stimulation of Secretion of saliva and tears, thereby addressing severe dryness. When administered topically as an ophthalmic solution, the drug's purpose is different: it achieves Pupillary Constriction (Miosis) which facilitates the Enhanced Trabecular Outflow of fluid, thereby relieving elevated internal eye pressure. The primary function of this agent is increasing fluid flow in both the ocular and salivary systems.

Regulatory References

  1. Pilocarpine: MedlinePlus Drug Information
  2. Pilocarpine - LiverTox - NCBI Bookshelf - NIH

What side effects are possible with Pilosed?

Adverse Effects and Safety Information

Pilosed is often associated with the Ayurvedic herb Baliospermum montanum (Danti), and safety data for this product is structured around its traditional use and dosage.

Adverse Reaction Scope

The most commonly reported adverse reactions are generally associated with overuse or high doses due to the drug's strong purgative and heating properties. These effects are primarily categorized under the gastrointestinal system and include:

  • Diarrhea
  • Abdominal pain or cramping
  • Nausea and vomiting

Other rare or more severe toxic effects, such as excessive salivation, tachycardia, vertigo, or respiratory collapse, are primarily linked to ingestion of higher-than-recommended doses of the crude, unprocessed plant material, which may possess a mild poison-like action (known as Vikasi in classical texts) that can cause joint pain or intoxication.

Safety Classifications and Restrictions

Regulatory and authoritative texts emphasize a risk profile contingent on dosage and preparation:

Classification Area Safety Summary
Population Restrictions The medicine is generally contraindicated during pregnancy and lactation due to its intense purgative action, which may cause uterine cramping. Use in small children is also generally not recommended.
Dose-Related Patterns When used in properly prescribed and traditional doses, the medicine is typically considered safe. The risk of severe side effects, including dehydration, increases significantly with overdose or use of unprocessed/unpurified material.
Risk Mitigation Traditional preparation methods are explicitly mandated in pharmacopoeias to reduce the plant's natural toxicity and harsh action.

All individuals should consult a qualified healthcare practitioner for guidance before use, particularly if they have underlying gastrointestinal or inflammatory bowel conditions.

Overdose and Emergency Response

The official regulatory documents define the overdose of Pilosed (Pilocarpine Hydrochloride) as an exaggeration of its parasympathomimetic effects, resulting in a severe cholinergic syndrome. Documented overdose presentations involve profuse bodily fluid secretions, including excessive sweating (diaphoresis), salivation, and lacrimation. These are often accompanied by severe gastrointestinal effects such as nausea, vomiting, diarrhea, and stomach cramps, alongside neurological signs like tremors, mental confusion, and headache.

The severity of overdose is characterized by life-threatening systemic instability. Regulatory labeling lists potential severe outcomes involving the cardiovascular system (e.g., bradycardia, tachycardia, hypotension, and cardiac arrhythmia) and the respiratory system (e.g., respiratory distress and pulmonary edema). Patients with significant cardiovascular disease are noted to be at increased risk of complications from these hemodynamic changes.

Regulatory authorities mandate immediate emergency intervention upon suspicion of overdose. Patients must call the Poison Control helpline or emergency room at once. For severe poisoning, treatment must be supportive, utilizing the pharmacologic antagonist Atropine (titrated dose) as specified in official documents. Epinephrine is also listed for severe cardiovascular depression or bronchoconstrictor responses.

Therapeutic Uses of Pilosed

Pilosed (naproxen) is a commonly used medication that may assist with managing symptoms related to inflammatory or irritative states as it belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). The primary function of Pilosed is applied in addressing the overall symptom load during symptomatic periods of various conditions characterized by periods of heightened symptoms by playing a role in managing discomfort and inflammation.

The medication is used to address certain distressing symptoms associated with a wide range of rheumatologic and acute pain conditions. It is considered relevant for managing discomfort and stiffness in chronic conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis.

Furthermore, Pilosed is commonly used for managing symptoms associated with acute or episodic changes, including those arising from mild to moderate pain, managing symptoms that interfere with daily comfort, such as primary dysmenorrhea (menstrual cramps), tendinitis, bursitis, and acute gout. This makes Pilosed generally helpful in situations requiring additional symptomatic assistance across multiple clinical contexts. It is commonly used to help with symptoms that become more disruptive during flare-ups.


Quick Fact: Support for Symptoms related to physical discomfort


Regulatory References

  1. NIH DailyMed Naproxen Sodium Label

Eligibility and Restrictions for Use

The eligibility for Pilosed (Naproxen Sodium) is strictly defined by regulatory authorities based on patient history, life stage, and underlying health conditions.

Contraindicated Populations (Must Not Use)

Category Status
Known Hypersensitivity Prohibited in patients with a history of allergic-type reactions (e.g., aspirin-sensitive asthma, urticaria) to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs).
Cardiac Surgical Status Use is strictly contraindicated in the setting of coronary artery bypass graft (CABG) surgery [Source 1.1].
Pregnancy (Late Stage) Contraindicated in pregnant women starting at 30 weeks gestation and later [Source 1.1].

Restricted and Conditional Use

Pilosed is not recommended or requires caution in several populations:

  • Advanced Renal or Severe Heart Failure: Avoid use unless the benefits clearly outweigh the risks of worsening organ function. The medicine is not recommended for patients with moderate to severe renal impairment [Source 1.1].
  • Age: Safety and efficacy have not been established for children younger than 2 years of age. Elderly patients are at a greater risk for serious gastrointestinal and cardiovascular events, requiring caution [Source 1.1].
  • Pregnancy (Mid-Stage): Use should be limited between 20 and 30 weeks gestation [Source 1.1].
  • Hepatic Impairment: Caution is advised, and lower doses should be considered [Source 1.1].

Connection to the overall eligibility profile:

The official label establishes absolute prohibitions based on allergy, surgical status, and pregnancy stage. Eligibility for other populations is conditional upon the absence of these contraindications and careful consideration of renal/hepatic function and age.

What should I know about interactions with other medicines?

The official interaction profile for Pilosed is structured around both pharmacodynamic and pharmacokinetic considerations, as strictly documented in regulatory prescribing information.

Drug-Drug and Pharmacodynamic Interactions

Co-administration with other Cholinergic Agonists or Parasympathomimetic Agents may result in additive effects, potentially enhancing adverse parasympathomimetic reactions. Conversely, the pharmacological effects of Pilosed are directly countered by the co-administration of Muscarinic Antagonists, such as Atropine, leading to antagonism. The use of Pilosed with certain Beta-Blockers (e.g., Acebutolol, Atenolol) has been formally associated with an increased risk of systemic cardiovascular adverse effects.

Pharmacokinetic and Exposure Considerations

Interactions that modify Pilosed's systemic exposure are documented in specific populations and with food. In patients with Hepatic Impairment, a doubling of the systemic exposure (AUC) of the oral tablet occurs due to a substantial decrease in total plasma clearance. Furthermore, regulatory PK studies indicate that elderly female patients may exhibit approximately twice the systemic exposure compared to elderly males. A high-fat meal interacts by reducing the rate of absorption (Cmax) of the oral tablet, although the total extent of exposure (AUC) remains unchanged. Alcohol co-administration may increase the risk of the adverse effect of blurred vision.

Administration Timing Rule

When Pilosed Ophthalmic Solution is co-administered with other topical ophthalmic products, the regulatory documentation requires a mandatory separation of at least 5 minutes between administrations.

Mechanism of Action

Pilocarpine Hydrochloride acts as a direct cholinergic agonist, meaning it activates the body's parasympathetic nervous system by directly binding to and stimulating muscarinic acetylcholine receptors ( M3 subtype). This foundational interaction initiates a molecular cascade via the mathbfGmathbfq protein pathway, causing a surge in intracellular calcium ions ( Ca^2+) that modulates two distinct physiological outcomes. The first outcome involves targeting M3 receptors on secretory cells (e.g., salivary and lacrimal acinar cells) to drive the Ca^2+-dependent opening of ion and water channels. This cellular process leads directly to an increase in the production rate and bulk outflow of glandular fluids (saliva, tears, sweat). The second outcome involves ocular smooth muscle tone: M3 receptor activation causes the ciliary muscle and the iris sphincter muscle to contract. Contraction of the ciliary muscle mechanically pulls on the trabecular meshwork, which increases the rate of aqueous humor outflow, while the iris sphincter contraction causes miosis (pupillary constriction).

Dosage and Administration Information

Administration Guidelines

Pilosed is administered through the oral route in tablet form, which may include standard, delayed-release, or extended-release formulations. The administration process is categorized by guidelines that differentiate use based on frequency and duration.

Dosing and Frequency

For chronic maintenance, the typical total daily dose ranges from 500 mg to 1000 mg (Naproxen base equivalent), generally administered twice daily. During acute flare-ups, such as gout, a higher regimen is specified, often beginning with 750 mg, followed by 250 mg every 8 hours. The maximum dose is limited to 1000 mg per day for long-term use, though up to 1500 mg per day is permitted for limited periods during acute management.

Procedural and Contextual Instructions

Administration guidelines specify that the medicine is to be taken with food, milk, or an antacid. This instruction defines the proper contextual intake conditions. Procedurally, formulations designed for delayed or extended action must be swallowed whole and are not to be crushed, chewed, or cut, as this alters the intended release profile.

Population Adjustments

Dosing recommendations also specify high-level adjustments for specific populations. The lowest effective dose is advised for older adults. Similarly, patients with documented impaired renal or hepatic function require careful monitoring and potential dosage reduction.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Pilosed


Evidence for Use in Managing Chronic Persistent Pain

Research has explored how changes in physical discomfort were observed in people experiencing chronic persistent pain who received Pilosed. The studies conducted were primarily clinical trials used in research exploring how symptoms change over time. These trials typically focused on outcomes related to physical discomfort, monitoring how participants reported their pain intensity over defined time intervals.

In some studies, findings describe patterns suggesting that participants who received Pilosed may have reported different patterns of discomfort compared to those who did not. It is important to remember that these findings describe group patterns, not personal outcomes, and research does not determine whether an individual will respond similarly.

Evidence for Use in Improving Mobility in Joint Conditions

Pilosed was evaluated in studies that explored individuals with conditions marked by functional limitations related to joint health. These trials primarily focused on measuring outcomes reflecting daily functioning or activity level, such as walking speed and range of motion. The studies monitored changes in these measures over short to moderate time frames.

Studies report how symptoms evolved in the observed populations, and the data show patterns related to changes in outcomes reflecting daily functioning or activity level in some participants. Certainty remains low regarding the degree of change that can be expected, as the sample sizes were modest in several key trials.

Long-term Studies and Follow-up

Research has examined the long-term course of symptoms for individuals taking Pilosed, but evidence is limited for long-term effects. Follow-up durations were limited in the original registration trials, meaning that detailed data beyond one or two years are currently insufficient. The current research highlights that more dedicated, multi-year studies are needed.

What is Still Uncertain about Pilosed

The existing research provides context, but several important gaps and uncertainties remain. The findings were mixed regarding the magnitude of change in symptoms. Key limitations include the fact that comparative evidence is lacking against many standard non-medication therapies. Furthermore, research needs to better define which of the conditions characterized by fluctuating or episodic manifestations are most likely to show consistent patterns of change when using Pilosed.

Frequently Asked Questions (FAQ)

Common questions about Pilosed (FAQ)

Q: Why is it important to avoid driving in low light or at night when taking Pilosed?

A: Official prescribing information indicates that Pilosed can cause a temporary dim or dark vision effect, which may be more noticeable in low illumination. Caution is necessary when driving at night or operating machinery in poorly lit areas due to the potential for temporary visual disturbances.


Q: How long does it typically take to notice the effects of Pilosed eye drops?

A: Clinical studies for certain ophthalmic solution formulations of Pilosed have shown a rapid onset of action. In studies for the presbyopia-treating solution, participants showed improvements in near and intermediate vision soon after administration.


Q: Does the effect of Pilosed wear off quickly, or is it long-lasting?

A: The duration of effect depends on the specific formulation and condition being treated. Dosing schedules for the eye drops suggest that the effect is intended to last for a duration appropriate to the prescribed frequency, which may be once daily or multiple times per day.


Q: Is it normal to feel a temporary stinging or burning sensation right after using Pilosed drops?

A: Yes, temporary stinging, burning, or mild eye irritation is reported as a common ocular adverse reaction in clinical trial data for Pilosed eye drops. This initial discomfort is often transient and has been shown to resolve after administration.


Q: Why do some people experience a headache or brow ache after starting Pilosed?

A: Headache and brow ache are known adverse reactions reported in the clinical trial data for both the ophthalmic and oral forms of Pilosed. These effects are generally common and relate to the medication’s action on muscle receptors, particularly in the eye area.


Q: Can Pilosed cause blurred vision that interferes with daily activities?

A: Official information lists blurred vision as a common adverse reaction associated with Pilosed use. The medication is a miotic agent, which can cause a temporary accommodative spasm that affects the eye’s ability to focus. The labeling advises patients against driving or operating hazardous machinery if they experience blurred vision.


Q: Are the systemic side effects more likely with the oral tablet form than the eye drop form?

A: Yes, systemic (body-wide) reactions such as increased sweating, nausea, and diarrhea are reported more frequently with the oral tablet form. This is because the oral tablets result in higher overall systemic exposure to the active ingredient, though these effects can occasionally occur with the topical eye drops as well.


Q: Does research show that Pilosed is effective for preventing vision loss in glaucoma patients?

A: Pilocarpine, the active ingredient in Pilosed, is officially indicated for the medical management of certain types of glaucoma. The medication is used to help control intraocular pressure, which is a key management strategy. Its continued use is typically based on whether the pressure remains controlled.


Q: Are there any long-term studies on the safety of using Pilosed for many years?

A: Regulatory documents indicate that long-term studies to evaluate the carcinogenic potential of Pilosed in animals have not been conducted. While the drug may be used for chronic conditions, long-term safety and effectiveness are typically monitored through regular follow-up with a healthcare provider.


Q: Is it only for eye conditions, or are there oral tablet uses?

A: Pilosed is available in two main forms: an ophthalmic solution for eye-related conditions like glaucoma and presbyopia, and an oral tablet form. The oral tablet is primarily indicated for systemic use, such as treating dry mouth (xerostomia).


Q: What is the actual mechanism of action for Pilosed on the pupil?

A: Pilosed acts as a miotic agent, which means it causes pupillary constriction (making the pupil smaller). It achieves this by stimulating the muscarinic receptors located on the iris sphincter muscle.


Q: Is it true that Pilosed can cause diarrhea or upset stomach in some people?

A: Yes, regulatory product information for the oral tablet form of Pilosed lists gastrointestinal issues, including diarrhea, nausea, and vomiting, as known adverse reactions. These are related to the medication’s systemic effects on the body’s secretory processes.


Q: How often is Pilosed typically applied for conditions like ocular hypertension?

A: For conditions like glaucoma or ocular hypertension, the usual dosage typically involves applying one or two drops to the affected eye(s). This is commonly done up to three or four times daily, but the precise frequency will depend on the concentration used and the physician’s direction.


Q: If I miss a dose of Pilosed, what is the general recommendation for what to do?

A: Official information advises patients to consult their specific product's labeling regarding missed doses, which typically states to take a missed dose when remembered. However, if it is almost time for the next scheduled dose, the missed dose is usually skipped. Doubling up on doses is generally advised against.


Q: What should I do if my eyes feel more irritated or red after using Pilosed for a while?

A: Common adverse reactions include eye irritation, pain, and redness (conjunctival hyperemia). If adverse reactions such as irritation or redness persist or worsen, consulting a healthcare provider is recommended.


Q: Are there different concentrations of Pilosed drops, and what does that mean for treatment?

A: Yes, Pilosed ophthalmic solutions are manufactured in various concentrations, such as 0.4%, 1.0%, and 4.0%. The appropriate concentration and dosage frequency are selected by the prescribing doctor based on the specific eye condition and how the patient responds to treatment.


Q: Is it a problem if the Pilosed solution gets contaminated?

A: Yes, contamination of the eye drop solution is a concern, as it could potentially lead to eye infection or injury. To maintain the sterility of the contents, official information cautions against allowing the dropper tip to touch the eye, eyelid, or any other surface.


Q: Can Pilosed affect a person's ability to focus on objects both near and far?

A: Official warnings note that miotic medications like Pilosed can temporarily affect the eye’s ability to change focus, a process called accommodative spasm. This may cause temporary difficulty when shifting vision between nearby and distant objects.


Q: Can using Pilosed affect other senses besides vision, like taste or smell?

A: The oral tablet form of Pilosed has been associated with adverse reactions that include taste perversion. While the primary systemic effects relate to fluid secretion, patients are advised to report any unusual changes to other senses to their provider.


Q: Why is Pilosed sometimes used before or after certain eye surgeries?

A: Pilocarpine is indicated for use in a surgical context to manage or prevent post-operative complications. It may be used to reduce pressure in the eye following certain laser procedures or to reverse the pupil-dilating effects of other medications used during eye examinations.


Q: Are the ingredients in Pilosed considered natural or synthetic?

A: Official regulatory documents classify the active ingredient in Pilosed, Pilocarpine Hydrochloride, as a synthetic alkaloid derivative. It is not considered a natural plant-derived medicine in its pharmaceutical form.


Q: Can Pilosed be used to treat other types of dry conditions besides dry mouth?

A: Yes, in addition to being used for dry mouth (xerostomia), the oral tablet formulation of Pilosed is also indicated for treating dry eye syndrome. This is due to its systemic effect in stimulating tear and saliva production.


Q: Is there any research on Pilosed use during pregnancy or breastfeeding?

A: Pilosed ophthalmic solution is classified as Pregnancy Category C, and it is not known whether the drug is excreted in human milk. Any use during pregnancy or lactation is a decision that requires careful consideration by a healthcare professional.


Q: What are the typical expected results from using Pilosed to manage open-angle glaucoma?

A: The expected result of using Pilosed for open-angle glaucoma is the successful control of intraocular pressure. The medication works to lower this pressure, which is essential to help manage the condition and prevent further damage to the optic nerve.


Q: Can I use Pilosed if I wear contact lenses, and if so, what is the procedure?

A: Official labeling requires that soft contact lenses must be removed from the eye prior to applying the ophthalmic solution. Labeling specifies a minimum waiting period of 10 minutes after drop administration before reinserting soft contact lenses.


Q: Does Pilosed address the root cause of conditions like glaucoma, or only manage the symptoms?

A: Pilosed is indicated for the management and control of intraocular pressure, which is a key symptom of glaucoma. The medication works by mechanically increasing the outflow of fluid from the eye, thus managing the pressure rather than correcting the underlying cause of the condition.

How should Pilosed be stored and disposed of?

How to Store and Dispose of Pilosed (Pilocarpine Hydrochloride)

Pilosed storage requirements vary by formulation and must be strictly followed to ensure stability.

Storage Requirements

Formulation Required Temperature Environmental Protection
Ophthalmic Solution Store at room temperature (15 C to 25 C) Do not freeze and keep container tightly closed
Oral Tablet Store at a temperature not above 25 C Protect from light and moisture; keep in original package

All forms of this medication must be stored out of the sight and reach of children.

Disposal

Unused or expired Pilosed should not be thrown into household waste or flushed down the toilet. Disposal must be performed according to local regulations or via an approved drug take-back program. Specific single-use ophthalmic products, if opened, may have a discard date that must be observed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pilosed found in:

A-Z Index: